Managing Myeloma
- 2012-02-16 - Cyclophosphamide-bortezomib-dexamethasone (CYBORD) produces rapid and complete hematological response in patients with AL amyloidosis -- Blood
- 2012-02-16 - High-Risk Myeloma Patients With Trisomies May Not Be High Risk After All -- Myeloma Beacon
- 2012-02-13 - OncoPep Enters Exclusive License Agreement with Dana-Farber for Novel Therapeutic Multi-Peptide Vaccine Technology for Hematologic Cancers -- BusinessWire/Market Watch
- 2012-02-04 - Siltuximab May Be Effective In Certain Patients With Advanced Multiple Myeloma (ASH 2011) -- The Myeloma Beacon
- 2012-01-31 - Note Worthy from ASH 2011: Novel Myeloma-Specific Multiple Peptides Able to Generate Cytotoxic T Lymphocytes: Potential Therapeutic Application in Multiple Myeloma and Other Plasma Cell Disorders
- 2012-01-26 - Celgene Updates Timeline For Pomalidomide Approval In The U.S. And Europe -- The Myeloma Beacon
- 2012-01-23 - Breaking News: FDA Approves Subcutaneous Administration of Bortezomib In All Approved Indications--Business Wire
- 2012-01-19 - The Multiple Myeloma Research Foundation (MMRF) Releases White Paper Outlining the Increasingly Important Role of Non-Profit Organizations in Drug Development
- 2012-01-18 - BT-062 Shows Activity In Patients With Advanced Myeloma (ASH 2011) -- The Myeloma Beacon
- 2011-12-23 - Multiple Myeloma Research Consortium (MMRC) Opens Record-Breaking Number of Trials in 2011 to Advance Multiple Myeloma Treatments -- MMRC PR Businesswire
- 2011-12-23 - Lenalidomide Maintenance Holds Back Myeloma in Elderly -- The Oncology Report
- 2011-12-22 - Secondary Malignancies Affirmed After Lenalidomide for Myeloma -- Digital Network
- 2011-12-22 - Multiple Myeloma Phase III Trial - Vorinostat Achieved Primary Endpoint -- Medical News Today
- 2011-12-21 - ASH 2011 Multiple Myeloma Update – Day Three Afternoon: Other New Therapies -- The Myeloma Beacon
- 2011-12-19 - The Multiple Myeloma Research Foundation (MMRF) Announces Four Leading Academic Cancer Centers as Clinical Sites for Landmark Study -- Business Wire